Novel biopanning strategy to identify epitopes associated with vaccine protection.
about
Peptide Vaccine: Progress and ChallengesBiocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesBDB: biopanning data bank.Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort studyChallenges in HIV Vaccine Research for Treatment and Prevention.The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trialMapping polyclonal antibody responses to bacterial infection using next generation phage display.Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides.Profiling the IgOme: meeting the challenge.Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.The value of HIV protective epitope research for informed vaccine design against diverse viral pathogensPhage-displayed peptides that mimic epitopes of hepatitis E virus capsid.Structure-based Epitope Mapping of Mycobacterium tuberculosis Secretary Antigen MTC28Identification of a highly conserved surface on Tat variants.Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.
P2860
Q26851329-79FDA6E1-42FA-429B-82D3-5BA174A7195AQ27333734-2698D540-4073-4614-A7CF-648C9CA92B4AQ33457718-041B35A1-1195-43B9-A64E-3C8F0B864DCDQ33603602-9BCB887C-1B84-44C3-825C-529104C0C44EQ33864926-8992E794-3E07-44E1-AADF-0785840EB1D6Q34148683-A446BE1F-C663-4CD2-AEB6-14318E624C92Q35040673-F266ACD8-2F4F-4100-8988-FA68AEB84B38Q35129224-23DC0A32-DC55-4073-BE5A-AEEF20E1206DQ35552889-1C49B160-742A-4BC0-AB5A-E3A18912C23FQ35987670-B3F48720-1C5B-4B05-812B-4FAF588B2C46Q36964284-F729F6BF-FB03-483B-8211-C9FF6A9E1149Q37054470-784907B8-21BD-4F35-AD54-520EFD6BE358Q37419985-14798261-80F8-461B-975D-2DDC5881E09DQ38123488-16B1C625-8B7A-4137-A223-C1ACAAEE088EQ38163241-13F8A822-1F9F-4638-9967-0E32C734C93AQ38533881-DDEE513E-7D99-4E99-90FC-5C627F1104C0Q39169929-497EA708-0421-4589-A39E-E5A53A40A665Q40231413-AA9A7175-488E-4A7A-A6BF-BFE19E062EF4Q40670691-D2569973-08C5-4701-AAC5-A5EDAAE9275EQ41468434-77A244D7-34EF-4A10-9679-BFF2D96C05C5Q42061242-C3DB8623-AE51-4474-845E-90B3149277F9
P2860
Novel biopanning strategy to identify epitopes associated with vaccine protection.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@ast
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@en
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@nl
type
label
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@ast
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@en
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@nl
prefLabel
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@ast
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@en
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@nl
P2093
P2860
P356
P1433
P1476
Novel biopanning strategy to identify epitopes associated with vaccine protection.
@en
P2093
Barbara C Bachler
Brisa Palikuqi
Michael Humbert
Robert A Rasmussen
Ruth M Ruprecht
Samir K Lakhashe
P2860
P304
P356
10.1128/JVI.02888-12
P407
P577
2013-02-06T00:00:00Z